High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH

被引:125
作者
Bruder, CEG
Hirvelä, C
Tapia-Paez, I
Fransson, I
Segraves, R
Hamilton, G
Zhang, XX
Evans, DG
Wallace, AJ
Baser, ME
Zucman-Rossi, J
Hergersberg, M
Boltshauser, E
Papi, L
Rouleau, GA
Poptodorov, G
Jordanova, A
Rask-Andersen, H
Kluwe, L
Mautner, V
Sainio, M
Hung, G
Mathiesen, T
Möller, C
Pulst, SM
Harder, H
Heiberg, A
Honda, M
Miimura, M
Sahlén, S
Blennow, E
Albertson, DG
Pinkel, D
Dumanski, JP [1 ]
机构
[1] Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden
[2] Karolinska Hosp, Dept Mol Med, SE-17176 Stockholm, Sweden
[3] Univ Uppsala Hosp, Dept Otorhinolaryngol & Head & Neck Surg, SE-75185 Uppsala, Sweden
[4] Univ Calif San Francisco, Dept Lab Med, Ctr Canc, San Francisco, CA 94143 USA
[5] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England
[6] INSERM, U434, Lab Genet Tumeurs, F-75010 Paris, France
[7] Univ Zurich, Inst Med Genet, CH-8001 Zurich, Switzerland
[8] Univ Zurich, Childrens Hosp, Div Pediat Neurol, CH-8032 Zurich, Switzerland
[9] Univ Florence, Dept Physiopathol, Med Genet Unit, I-500139 Florence, Italy
[10] Montreal Gen Hosp, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada
[11] Univ Hosp Queen Giovanna, Dept Neurosurg, BG-1527 Sofia, Bulgaria
[12] Lab Mol Pathol, BG-1431 Sofia, Bulgaria
[13] Klinikum Nord Ochsenzoll, Dept Neurol, D-22419 Hamburg, Germany
[14] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland
[15] House Ear Inst, Los Angeles, CA 90057 USA
[16] Karolinska Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden
[17] Sahlgrens Univ Hosp, Dept Audiol, SE-41335 Gothenburg, Sweden
[18] Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA
[19] Linkoping Univ Hosp, Dept Otorhinolaryngol, SE-58185 Linkoping, Sweden
[20] Univ Oslo, Rikshosp, Dept Med Genet, N-0027 Oslo, Norway
[21] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058461, Japan
[22] Univ Calif San Francisco, Ctr Canc, Inst Canc Res, San Francisco, CA 94143 USA
关键词
D O I
10.1093/hmg/10.3.271
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder whose hallmark is bilateral vestibular schwannoma. It displays a pronounced clinical heterogeneity with mild to severe forms. The NF2 tumor suppressor (merlin/schwannomin) has been cloned and extensively analyzed for mutations in patients with different clinical variants of the disease. Correlation between the type of the NF2 gene mutation and the patient phenotype has been suggested to exist. However, several independent studies have shown that a fraction of NF2 patients with various phenotypes have constitutional deletions that partly or entirely remove one copy of the NF2 gene. The purpose of this study was to examine a 7 Mb interval in the vicinity of the NF2 gene in a large series of NF2 patients in order to determine the frequency and extent of deletions. A total of 116 NF2 patients were analyzed using high-resolution array-comparative genomic hybridization (CGH) on an array covering at least 90% of this region of 22q around the NF2 locus. Deletions, which remove one copy of the entire gene or are predicted to truncate the schwannomin protein, were detected in 8 severe, 10 moderate and 6 mild patients. This result does not support the correlation between the type of mutation affecting the NF2 gene and the disease phenotype. This work also demonstrates the general usefulness of the array-CON methodology for rapid and comprehensive detection of small (down to 40 kb) heterozygous and/or homozygous deletions occurring in constitutional or tumor-derived DNA.
引用
收藏
页码:271 / 282
页数:12
相关论文
共 36 条
  • [1] Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
    Albertson, DG
    Ylstra, B
    Segraves, R
    Collins, C
    Dairkee, SH
    Kowbel, D
    Kuo, WL
    Gray, JW
    Pinkel, D
    [J]. NATURE GENETICS, 2000, 25 (02) : 144 - 146
  • [2] Misleading linkage results in an NF2 presymptomatic test owing to mosaicism
    Bijlsma, EK
    Wallace, AJ
    Evans, DGR
    [J]. JOURNAL OF MEDICAL GENETICS, 1997, 34 (11) : 934 - 936
  • [3] 50 PROBANDS WITH EXTRA STRUCTURALLY ABNORMAL CHROMOSOMES CHARACTERIZED BY FLUORESCENCE IN-SITU HYBRIDIZATION
    BLENNOW, E
    NIELSEN, KB
    TELENIUS, H
    CARTER, NP
    KRISTOFFERSSON, U
    HOLMBERG, E
    GILLBERG, C
    NORDENSKJOLD, M
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 55 (01): : 85 - 94
  • [4] Bruder CEG, 1999, GENE CHROMOSOME CANC, V25, P184, DOI 10.1002/(SICI)1098-2264(199906)25:2<184::AID-GCC15>3.0.CO
  • [5] 2-B
  • [6] The DNA sequence of human chromosome 22
    Dunham, I
    Shimizu, N
    Roe, BA
    Chissoe, S
    Dunham, I
    Hunt, AR
    Collins, JE
    Bruskiewich, R
    Beare, DM
    Clamp, M
    Smink, LJ
    Ainscough, R
    Almeida, JP
    Babbage, A
    Bagguley, C
    Balley, J
    Barlow, K
    Bates, KN
    Beasley, O
    Bird, CP
    Blakey, S
    Bridgeman, AM
    Buck, D
    Burgess, J
    Burrill, WD
    Burton, J
    Carder, C
    Carter, NP
    Chen, Y
    Clark, G
    Clegg, SM
    Cobley, V
    Cole, CG
    Collier, RE
    Connor, RE
    Conroy, D
    Corby, N
    Coville, GJ
    Cox, AV
    Davis, J
    Dawson, E
    Dhami, PD
    Dockree, C
    Dodsworth, SJ
    Durbin, RM
    Ellington, A
    Evans, KL
    Fey, JM
    Fleming, K
    French, L
    [J]. NATURE, 1999, 402 (6761) : 489 - 495
  • [7] Evans DA, 1998, KLUW S INF, V2, P63
  • [8] A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .2. GUIDELINES FOR GENETIC-COUNSELING
    EVANS, DGR
    HUSON, SM
    DONNAI, D
    NEARY, W
    BLAIR, V
    NEWTON, V
    STRACHAN, T
    HARRIS, R
    [J]. JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) : 847 - 852
  • [9] A GENETIC-STUDY OF TYPE-2 NEUROFIBROMATOSIS IN THE UNITED-KINGDOM .1. PREVALENCE, MUTATION-RATE, FITNESS, AND CONFIRMATION OF MATERNAL TRANSMISSION EFFECT ON SEVERITY
    EVANS, DGR
    HUSON, SM
    DONNAI, D
    NEARY, W
    BLAIR, V
    TEARE, D
    NEWTON, V
    STRACHAN, T
    RAMSDEN, R
    HARRIS, R
    [J]. JOURNAL OF MEDICAL GENETICS, 1992, 29 (12) : 841 - 846
  • [10] Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations
    Evans, DGR
    Trueman, L
    Wallace, A
    Collins, S
    Strachan, T
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (06) : 450 - 455